Evidence map›Paper›PMID 39697544›Full record

ArticleFrontiers in pharmacology2024

Ziwei Fang, Weimin Kong, Ziyi Zhao, Wenchuan Sun, Guangxu Xu, Leslie H Clark, Stephanie A Sullivan, Arthur-Quan Tran, Chang-Sheng Zhou, Delin Sun and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Frontiers in nutrition · 2026
    Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ziwei Fang *Department of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Healthcare Hospital, Beijing, China.
Weimin Kong *Department of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Healthcare Hospital, Beijing, China.
Ziyi ZhaoDepartment of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Healthcare Hospital, Beijing, China.
Wenchuan SunDivision of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Guangxu XuDepartment of Gynecology, Shanghai University of Medicine and Health Sciences Affiliated Sixth People's Hospital South Campus, Shanghai, China.
Leslie H ClarkDivision of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Stephanie A SullivanDivision of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Arthur-Quan TranDivision of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Chang-Sheng ZhouShandong Juxinyuan Asparagus Industry Development Research Institute, HeZe, Shandong, China.
Delin SunShandong Juxinyuan Asparagus Industry Development Research Institute, HeZe, Shandong, China.
Luyu ZhaoShandong Juxinyuan Agricultural Technology Co, LTD., HeZe, Shandong, China.
Jiandong WangDepartment of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Healthcare Hospital, Beijing, China.
Chunxiao ZhouDivision of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Victoria L Bae-JumpDivision of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.

Funding

UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · UNIV OF NORTH CAROLINA CHAPEL HILL · 2001 to 2025
$6.9M
NIEHS NIH HHS P30 ES010126
6 · The paper itself

Abstract

Introduction: Endometrial cancer is the most common malignancy of the female reproductive system in the United States. Methods: Endometrial cancer cells were used to study the effects of Results: Treatment with increasing concentrations of Discussion: These findings provide strong preclinical evidence for the potential therapeutic benefit of

Indexed as

apoptosisAsparagus officinalisendometrial cancerinvasionsynergytumor growth

Identifiers

PMID39697544
PMCPMC11653357

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.